Cita APA

Mora, P., Sutton, D. R., Gore, A., Baliga, B. S., Goldfaden, P., Nikkel, C., . . . Adams-Huet, B. (2020). OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes. J Endocr Soc.

Citación estilo Chicago

Mora, Pablo, David R. Sutton, Ashwini Gore, Bantwal S. Baliga, PharmD Goldfaden, Carla Nikkel, John Sink II, y Beverley Adams-Huet. "OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered By a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes." J Endocr Soc 2020.

Cita MLA

Mora, Pablo, et al. "OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered By a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes." J Endocr Soc 2020.